The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR‐HF study

E-ISSN： 1879-0844|17|3|329-339

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.3, 2015-03, pp. : 329-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous ferric carboxymaltose for heart failure with iron deficiency

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 134-135

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review

AUSTRALIAN AND NEW ZEALAND JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol. 58, Iss. 1, 2018-02 ,pp. : 22-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 20, Iss. 1, 2018-01 ,pp. : 125-133

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Safe and Novel Desensitization Protocol with Ferric Carboxymaltose to Treat Iron Deficiency Anemia

Current Drug Safety, Vol. 11, Iss. 2, 2016-04 ,pp. : 145-148

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of warm ischaemia time on postoperative renal function after partial nephrectomy for clinical T1 renal cell carcinoma: a propensity score‐matched study

BJU INTERNATIONAL, Vol. 121, Iss. 1, 2018-01 ,pp. : 46-52

John Wiley & Sons Inc

Access to resources Recommend Favorite